Listed by the USPTO as CLARKE, TRENT R
Tech Center 1600 • Art Units: 1651 1657 1678
This examiner grants 42% of resolved cases
CLARKE, TRENT R is a USPTO patent examiner in Tech Center 1600 and Art Unit 1651. The profile covers 443 resolved cases, a 42.2% allowance rate, and a 24.6% interview lift. The median time to allowance is 1382 days. The record indicates a moderate allowance outcome and a meaningful positive association between interviews and prosecution results.
The leading companies are Revival Animal Health LLC, Restem LLC, and The Regents of the University of Michigan. The leading firms are The Juhasz Law Firm, P.C., AMSTER, ROTHSTEIN & EBENSTEIN LLP, and CANTOR COLBURN LLP. Practitioners should plan for extended prosecution, use interviews to clarify disputed issues, and support those discussions with carefully targeted claim amendments and evidence.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17923679 | FUNCTIONALIZED POLY(GLYCEROL SEBACATE)S AND USES THEREOF | Final Rejection | CORNELL UNIVERSITY |
| 18190660 | Using Water Ponds for Capturing Dioxide and Growing Algae | Non-Final OA | Saudi Arabian Oil Company |
| 18684262 | METHODS COMPRISING THERAPEUTIC COMPOUNDS AND IN VITRO MAMMALIAN SKIN | Non-Final OA | AMGEN INC. |
| 18889325 | Methods and Compositions for Preserving Tissues and Organs | Non-Final OA | The General Hospital Corporation |
| 18003570 | CONTROLLING OPERATION OF A BIOREACTOR VESSEL | Non-Final OA | IPSEN BIOPHARM LIMITED |
| 18814678 | ENGINEERED PARASITES FOR DELIVERING PROTEIN TO THE CENTRAL NERVOUS SYSTEM (CNS) | Non-Final OA | The University Court of the University of Glasgow |
| 18739573 | CELL SAMPLE EVALUATION METHOD, CELL SAMPLE EVALUATION APPARATUS, AND CULTURE STATE ANALYSIS APPARATUS | Non-Final OA | HAMAMATSU PHOTONICS K.K. |
| 17425039 | MICROCARRIER FOR CELL CULTURE, METHOD FOR PRODUCING THE SAME, AND CELL CULTURE METHOD USING THE SAME | Non-Final OA | LG CHEM, LTD. |
| 19030781 | BALANCED SYSTEM AND METHOD FOR PRODUCTION OF MICROBIAL OUTPUT | Non-Final OA | Tenfold Technologies, LLC |
| 18704742 | RECOMBINANT YEAST CELL | Final Rejection | DANISCO US INC. |
| 18719120 | A METHOD FOR SEPARATING SUPERCOILED PLASMID DNA | Non-Final OA | Cytiva BioProcess R&D AB |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy42.2% of resolved applications examined by Trent R Clarke were allowed (443 resolved cases), compared with 31.5% across Art Unit 1651 over the last five years.
This examiner's interview lift is +24.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Trent R Clarke took 1,382 days on average from filing to allowance.
Trent R Clarke examines applications in Art Unit 1651 in Tech Center 1600 (Biotechnology & Pharmaceuticals).